A syringoma treatment device

Abstract

The application discloses a syringoma treatment device, which comprises a treatment body, a switch installed on the treatment body, a treatment head located at the head of the treatment body, an ultrasonic imaging module for obtaining an ultrasonic image of the syringoma including the thickness of the syringoma, a needle depth determination module for determining the needle depth of an electrolytic needle according to the thickness of the syringoma output by the ultrasonic imaging module, a treatment time determination module for determining the treatment time according to the thickness of the syringoma output by the ultrasonic imaging module, an image acquisition module for acquiring the image of the syringoma, a treatment current determination module for determining the treatment current according to the image of the syringoma acquired by the image acquisition module, a control module for sending a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current, and a pulse current generation module for generating and outputting a treatment pulse current to the treatment head according to the control instruction for generating and outputting the pulse treatment current.

Description

TECHNICAL FIELD

[0001] The present application relates to the field of electrolytic treatment, in particular a syringoma treatment device that can determine treatment time and treatment current intensity according to the condition. BACKGROUND

[0002] The syringoma treatment device is a physical treatment device that selectively destroys syringoma tissue through heat energy generated by high-frequency current. Its principle is: 1. Heat effect destruction: use high-frequency current needle tip to contact syringoma tissue to generate high temperature (up to several hundred degrees Celsius) instantly, denature and coagulate tumor cell proteins, and finally carbonize and necrose. 2. Precision: by controlling the current intensity and operation time, it can precisely act on the tumor and reduce damage to the surrounding normal tissue, especially suitable for sensitive parts such as eyelids. 3. Destroy blood vessels and ducts: the heat energy of the current can also destroy the capillaries and abnormal sweat gland ducts in the tumor, block the nutrient supply, and inhibit the regeneration of the tumor.

[0003] The syringoma treatment device is mainly suitable for small and dense, superficial syringoma, especially in areas that traditional laser cannot cover, such as eyelids and faces.

[0004] Most patients can completely shed the tumor after 1-3 treatments, and the skin surface returns to smooth. Studies have shown that if the operation is thorough, the recurrence rate is low.

[0005] Compared with surgical resection, electrolysis has less trauma and lower risk of postoperative scarring, making it suitable for patients with high appearance requirements and can relieve the itching or local irritation symptoms associated with syringoma.

[0006] Some patients need to be operated in stages (4-8 weeks apart) due to deep or densely distributed tumors to ensure complete removal. After electrolysis, the wound surface needs to be kept clean to avoid infection, and sunscreen is needed to reduce pigmentation.

[0007] Pulsed current (non-continuous, intermittent release of high-frequency current) is more controllable and precise in the treatment of syringoma than traditional continuous current. Its core mechanism of action includes: selective thermal injury and intermittent release of energy control to reduce cumulative heat effect; pulsed current through the "power on-pause" alternating mode avoids the heat diffusion caused by continuous heat production. Each pulse only releases energy for a very short time (microseconds to milliseconds), concentrating heat on syringoma tissue and reducing the risk of burning surrounding normal tissue.

[0008] High-intensity pulsed current can induce the formation of micropores in the cell membrane (electroporation effect), leading to ion imbalance between the inside and outside of the cell: disrupting the metabolic environment of syringoma cells and accelerating their death. The low heat diffusion property of pulsed current can be safely used in areas such as the eyelids and nasal wings to avoid scarring.

[0009] 2-10% of the skin sweat gland tumor, the current treatment is completed by electrolysis (by inserting a small needle into the sweat gland tumor, high temperature and chemical reaction are carried out by high frequency current, so that the sweat gland tumor tissue is gasified, carbonized and scabbed) Vascular lesions rely on doctors to identify lesions by naked eye, and there is a risk of missed diagnosis or positioning deviation. The treatment process relies on manual operation, and the degree of automation is low. The depth of electrode insertion, current intensity and action time need to be adjusted manually, and the experience difference of operators can easily lead to unstable curative effect. Insufficient standardization leads to a large number of treatments and large individual differences, resulting in uneven treatment of patients.

[0010] In addition, as a common benign tumor of skin appendages, the clinical diagnosis of sweat gland tumor mainly relies on the naked eye observation and experience judgment of doctors. However, due to the similar symptoms of sweat gland tumor and various skin diseases such as flat warts and millet papules, misdiagnosis and missed diagnosis often occur in actual diagnosis, which has an adverse effect on the timely treatment and physical and mental health of patients. SUMMARY

[0011] The purpose of the present application is to provide a sweat gland tumor treatment device capable of determining treatment time and treatment current intensity according to the condition.

[0012] According to the first embodiment of the present application, a sweat gland tumor treatment device comprises a treatment body, a switch mounted on the treatment body, a treatment head located at the head of the treatment body, an ultrasonic imaging module for obtaining an ultrasonic image of the sweat gland tumor including the thickness of the sweat gland tumor, a needle insertion depth determination module for determining the needle insertion depth of the electrolytic needle according to the thickness of the sweat gland tumor output by the ultrasonic imaging module, a treatment time determination module for determining the treatment time according to the thickness of the sweat gland tumor output by the ultrasonic imaging module, an image acquisition module for acquiring an image of the sweat gland tumor, a treatment current determination module for determining the treatment current according to the image of the sweat gland tumor acquired by the image acquisition module, a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current, and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head according to the control instruction for generating and outputting a pulse treatment current.

[0013] According to the second embodiment of the present application, a syringoma treatment device comprises a treatment body, a switch mounted on the treatment body, a treatment head located at the head of the treatment body, an image acquisition module for acquiring an image of a lesioned skin surface, a syringoma recognition module for recognizing a syringoma and a syringoma condition according to the lesioned skin surface acquired by the image acquisition module, an ultrasonic imaging module for acquiring an ultrasonic image of the syringoma including a thickness of the syringoma according to the syringoma recognition result output by the syringoma recognition module, a needle depth determination module for determining a needle depth of an electrolytic needle according to the thickness of the syringoma output by the ultrasonic imaging module, a treatment time determination module for determining a treatment time according to the thickness of the syringoma output by the ultrasonic imaging module, a treatment current determination module for determining a treatment current according to the syringoma condition output by the syringoma recognition module, a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current, and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head according to the control instruction for generating and outputting the pulse treatment current.

[0014] According to the third embodiment of the present application, a syringoma treatment device comprises a treatment body, a switch mounted on the treatment body, a treatment head located at the head of the treatment body, an ultrasonic imaging module for acquiring an ultrasonic image of the syringoma including a thickness of the syringoma, a needle depth determination module for determining a needle depth of an electrolytic needle according to the thickness of the syringoma output by the ultrasonic imaging module, a push-out mechanism for controlling the electrolytic needle on the treatment head to push out a corresponding length from the treatment head according to the determined needle depth, a treatment time determination module for determining a treatment time according to the thickness of the syringoma output by the ultrasonic imaging module, an image acquisition module for acquiring an image of the syringoma, a treatment current determination module for determining a treatment current according to the image of the syringoma acquired by the image acquisition module, a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current, and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head according to the control instruction for generating and outputting the pulse treatment current.

[0015] According to the fourth embodiment of the present application, a syringoma treatment device comprises a treatment body, a switch mounted on the treatment body, a treatment head with a treatment electrode at the head of the treatment body, an image acquisition module for acquiring an image of a lesioned skin surface, a syringoma recognition module for recognizing a syringoma and a syringoma condition according to the lesioned skin surface acquired by the image acquisition module, an ultrasound imaging module for acquiring an ultrasound image of the syringoma including a thickness of the syringoma according to a syringoma recognition result output by the syringoma recognition module, a needle insertion depth determination module for determining a needle insertion depth of an electrolytic needle according to the thickness of the syringoma output by the ultrasound imaging module, a push-out mechanism for controlling the electrolytic needle to be pushed out by a corresponding length from the treatment head according to the determined needle insertion depth, a treatment time determination module for determining a treatment time according to the thickness of the syringoma output by the ultrasound imaging module, a treatment current determination module for determining a treatment current according to the syringoma condition output by the syringoma recognition module, a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current, and a pulse current generation module for generating and outputting the treatment pulse current to the electrolytic needle of the treatment head according to the control instruction for generating and outputting the pulse treatment current.

[0016] The first to fourth embodiments of the present application further comprise a display module for displaying the needle insertion depth, the treatment time and the treatment current.

[0017] Preferably, the push-out mechanism is a micro hydraulic mechanism or a micro electric push rod, and the push-out mechanism controls the electrolytic needle to be pushed out from the treatment head according to the corresponding relationship between the needle insertion depth and a push-out time according to the needle insertion depth output by the needle insertion depth determination module.

[0018] Preferably, the treatment current determination module comprises a color extraction unit for extracting a color feature from the syringoma image, and a treatment current intensity unit for determining the treatment current according to the color feature.

[0019] Preferably, the treatment current intensity unit looks up a treatment current intensity of a syringoma with the same color feature in a database according to the extracted color feature, and takes the looked-up treatment current intensity as the treatment current.

[0020] Preferably, the treatment time determination module takes a treatment time corresponding to the thickness of the syringoma in the database as the treatment time of the syringoma.

[0021] Preferably, the syringoma recognition module compares a syringoma contour feature of a known syringoma skin surface sample image with a contour feature of the lesioned skin surface image, and if the two features are the same, the lesioned skin surface is recognized as a syringoma.

[0022] Preferably, the syringoma recognition module inputs the denoised lesioned skin surface image into a trained Transformer network to recognize the syringoma.

[0023] The present application can control the depth of current action by precisely adjusting the penetration depth through adjusting the pulse frequency and pulse width (single pulse duration). High frequency short pulse width (such as above 100 kHz) mainly acts on the epidermis layer, which is suitable for superficial eccrine angiomatous tumor; low frequency long pulse width can penetrate to the dermis layer, which is suitable for processing deep lesions.

[0024] The pulse current generated by the present application can destroy the eccrine angiomatous tumor while protecting the normal tissue to the maximum, and its core advantage is safer, more comfortable and lower recurrence rate, which is especially suitable for patients with high aesthetic requirements. BRIEF DESCRIPTION OF DRAWINGS

[0025] Figure 1 is a schematic diagram of the first embodiment of the appearance of the eccrine angiomatous tumor treatment device of the present application;

[0026] Figure 2 is one of the principle diagrams of the eccrine angiomatous tumor treatment device of the present application;

[0027] Figure 3 is the second principle diagram of the eccrine angiomatous tumor treatment device of the present application;

[0028] Figure 4a and Figure 4b are respectively schematic diagrams of the second embodiment of the appearance of the eccrine angiomatous tumor treatment device of the present application;

[0029] Figure 5 is the third principle diagram of the eccrine angiomatous tumor treatment device of the present application;

[0030] Figure 6 is the fourth principle diagram of the eccrine angiomatous tumor treatment device of the present application;

[0031] Figure 7 is a schematic diagram of the treatment effect of the eccrine angiomatous tumor treatment device of the present application. DETAILED DESCRIPTION

[0032] Figure 1 The first embodiment of the appearance of the eccrine angiomatous tumor treatment device of the present application is shown, which includes an ultrasonic imaging module 300, an image acquisition module 400, a display module 500 and a treatment body 100. The treatment body 100 is provided with a switch 600 for connecting the power supply of the eccrine angiomatous tumor treatment device, and a treatment head 200, and the treatment head 200 is provided with one or more electrolytic needles 210, each of which has a positive electrode and a negative electrode, and is provided with a scale for displaying the depth of penetration into the skin. The ultrasonic imaging module 300, the image acquisition module 400 and the display module 500 can be installed on the treatment body 100 or outside the treatment body 100. The image acquisition module 400 can be a camera module on a smart phone or a camera.

[0033] Figure 2 The present application is suitable for Figure 1The first embodiment of the syringoma treatment device shown includes an ultrasonic imaging module 300 for obtaining an ultrasonic image of a syringoma including the thickness of the syringoma; a needle depth determination module 110 for determining the depth of insertion of an electrolytic needle according to the thickness of the syringoma output by the ultrasonic imaging module 300; a treatment time determination module 120 for determining the treatment time according to the thickness of the syringoma output by the ultrasonic imaging module 300; an image acquisition module 400 for acquiring an image of the syringoma; a treatment current determination module 130 for determining the treatment current according to the image of the syringoma acquired by the image acquisition module 400; a control module 140 for issuing a control instruction for generating and outputting a pulsed treatment current according to the determined treatment time and treatment current; and a pulsed current generation module 150 for generating and outputting a treatment pulsed current to the electrolytic needle 210 of the treatment head 200 according to the control instruction for generating and outputting a pulsed treatment current. Specifically, the pulsed current generation module 150 generates a pulsed current with a pulse width equal to the treatment time and a current intensity equal to the determined current intensity according to the control instruction.

[0034] Referring to Figure 2 The output end of the ultrasonic imaging module 300 is connected to the input ends of the needle depth determination module 110 and the treatment time determination module 120, respectively. The output end of the image acquisition module 400 is connected to the input end of the treatment current determination module 130. The input ends of the control module 140 are connected to the output ends of the treatment current determination module 130 and the treatment time determination module 120, respectively. The output end of the control module 140 is connected to the input end of the pulsed current generation module 150.

[0035] The input ends of the display module 500 are connected to the output ends of the needle depth determination module 110 and the pulsed current generation module 150, respectively, for displaying the needle depth, treatment time, and treatment current, respectively.

[0036] In one example, the treatment current determination module 130 includes a color extraction unit for extracting color features from the image of the syringoma, i.e., extracting red, blue, and green pixels; and a treatment current intensity unit for determining the treatment current according to the color features. The treatment current intensity unit looks up the database for a known syringoma treatment current intensity with the same color features according to the extracted color features, and takes the found current intensity as the treatment current.

[0037] The database of the present application stores a large amount of known syringoma image data, the color features of which correspond to treatment current intensities that have been tested. Thus, the treatment current intensity unit can obtain a verified effective treatment current intensity from the database through the input image color features.

[0038] In another example, the treatment current determination module 130 can be a trained deep neural network for outputting a syringoma treatment current intensity according to the input image color features.

[0039] The database of the present application also stores a verified correspondence table of eccrine poroma thickness and treatment time, and the treatment time determination module 120 can find the treatment time corresponding to the eccrine poroma thickness from the database.

[0040] The present application can identify the boundary of the eccrine poroma through an edge detection algorithm (such as the Canny edge detector) and calculate its area. The shape features of the eccrine poroma are quantified using shape descriptors (such as Hu moments). The color features of the eccrine poroma are extracted through color space conversion (such as from RGB to HSV) and color histogram calculation.

[0041] The working principle of the first embodiment of the present application is that after the switch 66 turns on the working power supply of the module, the ultrasonic imaging module 300 acquires the ultrasonic image of the eccrine poroma thickness, the needle depth determination module 110 acquires the eccrine poroma thickness data from the ultrasonic image to determine the needle insertion depth, and the display module 500 displays the needle insertion depth to guide the doctor to insert the electrolytic needle 210 into the patient's lesion skin. The treatment time determination module 120 determines the treatment time according to the eccrine poroma thickness. The image acquisition module 400 sends the acquired image to the treatment current determination module 130, so that the treatment current determination module 130 determines the treatment current intensity according to the color features of the image. The control module 140 sends control instructions to the pulse current generation module 150 according to the received treatment time and treatment current intensity data, so that the pulse current generation module 150 generates a pulse current with a pulse width equal to the treatment time and a current intensity equal to or equivalent to the determined current intensity, and sends the pulse current to the electrolytic needle 210.

[0042] Figure 7 The treatment effect of the eccrine poroma treatment device of the present application is shown. Figure 7 The left column shows the image before treatment; Figure 7 The right column shows the image three months after treatment, and the eccrine poroma in the eye is obviously eliminated.

[0043] Figure 3 The eccrine poroma treatment device of the present application is shown. Figure 1 The second embodiment of the present application shown in the figure includes an ultrasonic imaging module 300, an image acquisition module 400, a display module 500, and a treatment body 100. The treatment body 100 is provided with a switch 600 for turning on the power supply of the eccrine poroma treatment device, and a treatment head 200, and the treatment head 200 is provided with one or more electrolytic needles 210.

[0044] Referring to Figure 3, the second embodiment of the syringoma treatment device further comprises: an image acquisition module 400 for acquiring images of the lesioned skin surface; a syringoma recognition module 160 for recognizing syringomas and the conditions of the syringomas according to the images of the lesioned skin surface acquired by the image acquisition module 400; an ultrasonic imaging module 300 for starting to acquire ultrasonic images of the syringomas including the thickness of the syringomas according to the syringoma recognition result output by the syringoma recognition module 160; a needle insertion depth determination module 110 for determining the needle insertion depth of the electrolytic needle according to the thickness of the syringomas output by the ultrasonic imaging module 300; a treatment time determination module 120 for determining the treatment time according to the thickness of the syringomas output by the ultrasonic imaging module 300; a treatment current determination module 130 for determining the treatment current according to the conditions (mild, moderate, severe) of the syringomas output by the syringoma recognition module 160; a control module 140 for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current; and a pulse current generation module 150 for generating and outputting a treatment pulse current to the electrolytic needle 210 of the treatment head 200 according to the control instruction for generating and outputting the pulse treatment current. The pulse current generation module 150 generates a pulse current with a pulse width equal to the treatment time and a current intensity equal to or equivalent to the determined current intensity according to the control instruction.

[0045] Referring to Figure 3 The output end of the image acquisition module 400 is connected to the input end of the syringoma recognition module 160. The two output ends of the syringoma recognition module 160 are respectively connected to the input end of the ultrasonic imaging module 300 and the input end of the treatment current determination module. The output end of the ultrasonic imaging module 300 is respectively connected to the input end of the needle insertion depth determination module 110 and the input end of the treatment time determination module 130. The output ends of the treatment current determination module 130 and the treatment time determination module 120 are respectively connected to the input ends of the control module 140. The output end of the control module 140 is connected to the input end of the pulse current generation module 150.

[0046] The main difference between the second embodiment and the first embodiment of the present application is that the syringoma recognition module 160 judges whether the lesioned skin of the patient is a syringoma according to the image of the skin lesion, and recognizes the condition of the syringoma. The ultrasonic imaging module 300 and the treatment current determination module 130 operate according to the recognition result of the syringoma recognition module 160. That is, only when the syringoma recognition module 160 judges that the lesioned skin of the patient is a syringoma, the syringoma treatment device of the present application can work. When the syringoma recognition module 160 judges that the lesioned skin of the patient is not a syringoma, the ultrasonic imaging module 300, the needle insertion depth determination module 110, the treatment time determination module 130 and the pulse current generation module 150 all terminate operation.

[0047] In one example, the syringoma identification module 160 compares the syringoma contour features of the known syringoma skin surface sample image and the contour features of the lesion skin surface image, and if they are the same, it is identified as a syringoma.

[0048] In another example, the syringoma identification module 160 identifies syringoma by inputting the denoised lesion skin surface image into the trained Transformer network.

[0049] The present application based on the syringoma identification of the Transformer network can accurately extract the key features of the syringoma image, improve the identification accuracy of the syringoma, and provide reliable technical support for the clinical diagnosis of doctors.

[0050] The Transformer network can use the following modules:

[0051] Data acquisition and preprocessing module: Use high-resolution skin image acquisition equipment such as professional dermatoscope or high-definition medical camera to collect skin image data of syringoma patients in a standard lighting environment. The collected images should cover syringoma samples of different parts and different development stages. Preprocess the collected raw images, including image denoising, using bilateral filtering algorithm to remove noise interference in the image; image enhancement, enhance the image contrast through histogram equalization; image normalization, map the image pixel value to the [0,1] interval to eliminate brightness deviation caused by differences in acquisition equipment.

[0052] Image blocking and position encoding module: divide the preprocessed image into multiple fixed-size image blocks, each image block as the input unit of the Transformer network. Add position encoding to each image block to carry the position information in the original image, so that the Transformer network can understand the spatial relationship between image blocks. Position encoding uses a combination of sine and cosine functions to generate, which is added to the feature vector of the image block and input to the Transformer network.

[0053] Transformer feature extraction module: build a feature extraction network based on the Transformer architecture, which contains multiple Transformer blocks. Each Transformer block consists of a multi-head self-attention mechanism (Multi-Head Attention) and a feed-forward neural network (Feed-Forward Network). In the multi-head self-attention mechanism, the attention weights between image blocks are calculated in parallel through different attention heads, capturing multi-scale features and global dependencies of the image. The feed-forward neural network further transforms and fuses the features output by the self-attention mechanism, enhancing the feature expression ability.

[0054] Feature classification and diagnosis module: input the sweat duct tumor image features extracted by the Transformer network into the classifier, and the classifier realizes by using the full connection neural network combined with the Softmax function. The full connection neural network performs dimension reduction processing and nonlinear mapping on the features, and the Softmax function converts the output feature vector into the probability distribution of each category, so as to judge whether the input image is a sweat duct tumor, and identify the type (such as eyelid type, rash type, etc.) and severity (mild, moderate, severe) of the sweat duct tumor.

[0055] Model training and optimization module: a large number of sweat duct tumor image datasets are used to train the above model, and a cross-entropy loss function is used to measure the difference between the model prediction result and the true label during the training process. The model parameters are updated by using the Adam optimizer, the learning rate and other hyperparameters are adjusted, and the model is iteratively trained several times to converge to the optimal state, so as to improve the recognition accuracy and generalization ability of the model. Among them, we use the Dice loss function for image classification training, and the loss function is defined as:

[0056]

[0057] Where y is the real mask, is the predicted mask, is the number of intersection pixels, |y| and are the number of pixels of the real mask and the predicted mask, respectively, and ∈ is a small smoothing term to avoid division by zero.

[0058] The present application solves the problems of traditional image recognition technology in processing sweat duct tumor images, such as incomplete feature extraction, limited learning ability for complex image features, etc.

[0059] Figure 4a and Figure 4b shows a second embodiment of the sweat duct tumor treatment device. In Figure 4a , the electrolysis needle 210 is retracted into the treatment head 200. In Figure 4b , the electrolysis needle 210 is extended from the treatment head 200.

[0060] Figure 5 shows a third embodiment of the present application suitable for the sweat duct tumor treatment device shown in Figure 4a and Figure 4b , which comprises a treatment body 100, a switch 600 mounted on the treatment body, and a treatment head 200 with an electrolysis needle 210 located at the head of the treatment body.

[0061] The third embodiment of the present application further comprises: an ultrasonic imaging module 300 for obtaining the ultrasonic image of the syringoma including the thickness of the syringoma; a needle insertion depth determination module 110 for determining the needle insertion depth of the electrolytic needle according to the thickness of the syringoma output by the ultrasonic imaging module 300; a pushing mechanism 230 for controlling the electrolytic needle on the treatment head 200 to be pushed out of the treatment head 200 by a corresponding length according to the determined needle insertion depth; a treatment time determination module 120 for determining the treatment time according to the thickness of the syringoma output by the ultrasonic imaging module 300; an image acquisition module 400 for acquiring the image of the syringoma; a treatment current determination module 130 for determining the treatment current according to the image of the syringoma acquired by the image acquisition module 400; a control module 140 for issuing a control instruction for generating and outputting the pulsed treatment current according to the determined treatment time and treatment current; a pulsed current generation module 150 for generating and outputting the treatment pulsed current to the treatment head 200 according to the control instruction for generating and outputting the pulsed treatment current; and a display module 500 for displaying the needle insertion depth, the treatment time and the treatment current.

[0062] The main difference between the third embodiment of the present application and the first embodiment is that the treatment head 200 is provided with a pushing mechanism 230, and the electrolytic needle 210 is installed on the pushing mechanism 230. The needle insertion depth determination module 110 sends the needle insertion depth data to the treatment head 200, and the treatment head 200 controls the pushing mechanism 230 to travel a corresponding distance to push the electrolytic needle 210 out of the treatment head 200 according to the needle insertion depth data.

[0063] The pushing mechanism 230 can be a micro hydraulic mechanism (hydraulic cylinder) or a micro electric push rod. According to the needle insertion depth output by the needle insertion depth determination module 110, the pushing mechanism 230 controls the electrolytic needle 210 to be pushed out of the treatment head 200 according to the corresponding relationship between the needle insertion depth and the pushing time.

[0064] The third embodiment of the present application has the advantage that the electrolytic needle 210 can be automatically inserted into the syringoma cortex according to the determined needle insertion depth, and the medical staff only need to place the treatment head 200 shown in the figure on the skin surface, and the pushing mechanism 230 can insert the electrolytic needle 210 in the treatment head 200 into the root of the syringoma, thereby improving the treatment efficiency. Figure 4a

[0065] Figure 6 The fourth embodiment of the present application suitable for the syringoma treatment device shown in Figure 4a and Figure 4b The fourth embodiment of the present application comprises a treatment body 100, a switch 600 installed on the treatment body, and a treatment head 200 with one or more electrolytic needles 210 located at the head of the treatment body.

[0066] ​The fourth embodiment of the present application also includes an image acquisition module 400 for acquiring images of the lesioned skin surface; a syringoma identification module 160 for identifying syringomas and the conditions of the syringomas according to the images of the lesioned skin surface acquired by the image acquisition module 400; an ultrasound imaging module 300 for starting to acquire ultrasound images of the syringomas including the thickness of the syringomas according to the syringoma identification results output by the syringoma identification module 160; a needle insertion depth determination module 110 for determining the needle insertion depth of the electrolysis needle according to the thickness of the syringomas output by the ultrasound imaging module 300; a push-out mechanism 230 for controlling the electrolysis needle to be pushed out by a corresponding length from the treatment head 200 according to the determined needle insertion depth; a treatment time determination module 120 for determining the treatment time according to the thickness of the syringomas output by the ultrasound imaging module 300; a treatment current determination module 130 for determining the treatment current according to the conditions of the syringomas output by the syringoma identification module 160; a control module 140 for issuing a control instruction for generating and outputting a pulsed treatment current according to the determined treatment time and treatment current; a pulsed current generation module 150 for generating and outputting the treatment pulsed current to the treatment head 200 according to the control instruction for generating and outputting the pulsed treatment current; and a display module 500 for displaying the needle insertion depth, the treatment time and the treatment current.

[0067] The main difference between the fourth embodiment of the present application and the third embodiment is that the syringoma identification module 160 judges whether the lesioned skin of the patient is a syringoma and identifies the condition of the syringoma according to the images of the skin lesion. The ultrasound imaging module 300 and the treatment current determination module 130 operate according to the identification results of the syringoma identification module 160. That is, only when the syringoma identification module 160 judges that the lesioned skin of the patient is a syringoma, the syringoma treatment device of the present application can work. When the syringoma identification module 160 judges that the lesioned skin of the patient is not a syringoma, the ultrasound imaging module 300, the needle insertion depth determination module 110, the treatment time determination module 130 and the pulsed current generation module 150 all terminate operation.

[0068] In summary, the present application can perform in-depth analysis on the identified syringoma to understand its properties, severity and other information. The analysis results can be presented to the patient or the doctor in an intuitive way, so that the doctor can understand the syringoma.

[0069] In addition, the present application can also automatically adjust the current intensity and treatment time of electrolytic treatment and the depth of electrode penetration according to the severity of the condition of the syringoma, to ensure the accuracy and effectiveness of the treatment.

[0070] Although the present application has been described in detail above, the present application is not limited thereto, and those skilled in the art can make various modifications according to the principles of the present application. Therefore, any modification made according to the principles of the present application should be understood as falling within the scope of the present application.

Claims

1. A syringoma treatment device for determining treatment time and treatment current intensity according to the condition, used for electrolytic treatment of syringomas, comprising a treatment body (100), a switch (600) mounted on the treatment body; and a treatment head (200) with an electrolytic needle (210) located at the head of the treatment body, characterized in that... Also includes: An ultrasound imaging module (300) for obtaining ultrasound images of syringomas, including the thickness of the syringoma. The needle depth determination module (110) determines the insertion depth of the electrolytic needle (210) into the patient's lesion skin based on the thickness of the syringoma output by the ultrasound imaging module (300). Treatment time determination module (120) determines treatment time based on the thickness of syringoma output by ultrasound imaging module (300). Image acquisition module (400) for acquiring images of syringomas; A treatment current determination module (130) determines the intensity of the treatment current based on the syringoma image acquired by the image acquisition module (400). A control module (140) issues a pulsed therapeutic current control command based on the treatment time determined by the treatment time determination module (120) and the therapeutic current intensity determined by the therapeutic current determination module (130). According to the pulse therapy current control command output by the control module (140), a pulse current generation module (150) generates and outputs the therapy pulse current to the treatment head (200). The pulse current generation module (150) generates a pulse current with a pulse width equal to the determined treatment time and a current intensity equal to or equivalent to the determined current intensity according to the pulse treatment current control command.

2. A syringoma treatment device for determining treatment time and treatment current intensity according to the condition, used for electrolytic treatment of syringomas, comprising a treatment body (100), a switch (600) mounted on the treatment body; and a treatment head (200) with an electrolytic needle (210) located at the head of the treatment body, characterized in that... Also includes: Image acquisition module (400) for acquiring images of the surface of diseased skin; Based on the image acquisition module (400) acquiring the lesion skin surface to identify syringomas and the syringoma condition identification module (160). Based on the syringoma recognition results output by the syringoma recognition module (160), the ultrasound imaging module (300) begins to acquire ultrasound images of the syringoma, including the thickness of the syringoma. The needle depth determination module (110) determines the insertion depth of the electrolytic needle (210) into the patient's lesion skin based on the thickness of the syringoma output by the ultrasound imaging module (300). Treatment time determination module (120) determines treatment time based on the thickness of syringoma output by ultrasound imaging module (300). Treatment current determination module (130) determines the intensity of treatment current based on the syringoma condition output by the syringoma identification module (160). A control module (140) issues a control command for generating and outputting a pulsed therapeutic current based on the treatment time determined by the treatment time determination module (120) and the therapeutic current intensity determined by the therapeutic current determination module (130). According to the pulse therapy current control command output by the control module (140), a pulse current generation module (150) generates and outputs a therapy pulse current to the treatment head (200). The pulse current generation module (150) generates a pulse current with a pulse width equal to the determined treatment time and a current intensity equal to or equivalent to the determined current intensity according to the pulse treatment current control command.

3. A syringoma treatment device for determining treatment time and treatment current intensity according to the condition, used for electrolytic treatment of syringomas, comprising a treatment body (100), a switch (600) mounted on the treatment body; and a treatment head (200) with an electrolytic needle (210) located at the head of the treatment body, characterized in that... Also includes: An ultrasound imaging module (300) for obtaining ultrasound images of syringomas, including the thickness of the syringoma. The insertion depth determination module (110) determines the insertion depth of the electrolytic needle (210) based on the thickness of the syringoma output by the ultrasound imaging module (300). According to the determined needle insertion depth, the electrolytic needle (210) on the treatment head (200) is pushed out of the treatment head (200) by the corresponding length of the ejection mechanism (230). Treatment time determination module (120) determines treatment time based on the thickness of syringoma output by ultrasound imaging module (300). Image acquisition module (400) for acquiring images of syringomas; A treatment current determination module (130) determines the intensity of the treatment current based on the syringoma image acquired by the image acquisition module (400). A control module (140) issues a control command for generating and outputting a pulsed therapeutic current based on the treatment time determined by the treatment time determination module (120) and the therapeutic current intensity determined by the therapeutic current determination module (130). According to the pulse therapy current control command output by the control module (140), a pulse current generation module (150) generates and outputs a therapy pulse current to the treatment head (200). The pulse current generation module (150) generates a pulse current with a pulse width equal to the determined treatment time and a current intensity equal to or equivalent to the determined current intensity according to the pulse treatment current control command.

4. A syringoma treatment device for determining treatment time and treatment current intensity according to the condition, used for electrolytic treatment of syringomas, comprising a treatment body (100), a switch (600) mounted on the treatment body; and a treatment head (200) with an electrolytic needle (210) located at the head of the treatment body, characterized in that... Also includes: Image acquisition module (400) for acquiring images of the surface of diseased skin; Based on the image acquisition module (400) acquiring the lesion skin surface, a syringoma identification module (160) identifies syringomas and syringoma conditions. Based on the syringoma recognition results output by the syringoma recognition module (160), the ultrasound imaging module (300) begins to acquire ultrasound images of the syringoma, including the thickness of the syringoma. The insertion depth determination module (110) determines the insertion depth of the electrolytic needle (210) based on the thickness of the syringoma output by the ultrasound imaging module (300). An ejection mechanism (230) for controlling the ejection of the electrolytic needle from the treatment head (200) by a corresponding length according to the determined needle insertion depth. Treatment time determination module (120) determines treatment time based on the thickness of syringoma output by ultrasound imaging module (300). Treatment current determination module (130) determines the intensity of treatment current based on the syringoma condition output by the syringoma identification module (160). A control module (140) issues a control command for generating and outputting a pulsed therapeutic current based on the treatment time determined by the treatment time determination module (120) and the therapeutic current intensity determined by the therapeutic current determination module (130). According to the pulse therapy current control command output by the control module (140), a pulse current generation module (150) generates and outputs a therapy pulse current to the treatment head (200). The pulse current generation module (150) generates a pulse current with a pulse width equal to the determined treatment time and a current intensity equal to or equivalent to the determined current intensity according to the pulse treatment current control command.

5. The syringoma treatment device according to any one of claims 1-4 further includes a display module (500) for displaying needle insertion depth, treatment time, and treatment current.

6. The syringoma treatment device according to claim 4, wherein the ejection mechanism (230) controls the ejection mechanism (230) to eject the electrolytic needle from the treatment head (200) according to the needle insertion depth output by the needle insertion depth determination module (110) and the corresponding relationship between the needle insertion depth and the ejection time.

7. A syringoma treatment device according to any one of claims 1-4, wherein the treatment current determining module (130) comprises: Color extraction unit for extracting color features from syringoma images; The therapeutic current intensity unit determines the magnitude of the therapeutic current based on the color characteristics.

8. The syringoma treatment device according to claim 7, wherein the treatment current intensity unit searches the database for known syringoma treatment current intensities with the same color characteristics based on the extracted color features, and uses the found current intensity as the treatment current.

9. A syringoma treatment device according to any one of claims 1-4, wherein the treatment time determination module (120) finds the treatment time corresponding to the thickness of the syringoma in the database and uses it as the syringoma treatment time.

10. A syringoma treatment device according to claim 2 or 4, wherein the syringoma recognition module (160) identifies syringomas by inputting the denoised image of the lesion skin surface into a trained Transformer network.

Images